Expression and alteration of insulin-like growth factor II-messenger RNA in hepatoma tissues and peripheral blood of patients with hepatocellular carcinoma

被引:82
作者
Dong, Zhi-Zhen [2 ]
Yao, Deng-Fu [1 ]
Yao, Deng-Bing [3 ]
Wu, Xin-Hua [1 ]
Wu, Wei [1 ]
Qiu, Li-Wei [1 ]
Jiang, Dao-Rong [2 ]
Zhu, Jian-Hua [2 ]
Meng, Xian-Yong [2 ]
机构
[1] Nantong Univ, Affiliated Hosp, Res Ctr Clin Mol Biol, Nantong 226001, Jiangsu Provinc, Peoples R China
[2] Nantong Univ, Affiliated Hosp, Dept Internal Med, Nantong 226001, Jiangsu Provinc, Peoples R China
[3] Nantong Univ, Inst Neurosci, Nantong 226001, Jiangsu Provinc, Peoples R China
关键词
IGF-II; Hepatocellular carcinoma;
D O I
10.3748/wjg.v11.i30.4655
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To investigate the clinical values of serum free insulin-like growth factor II (IGF-II) levels and IGF-II mRNA in hepatocellular carcinoma (HCC) tissues and peripheral blood for diagnosis of HCC and monitoring of extrahepatic metastasis. METHODS: Total RNAs were extracted from HCC tissues or peripheral blood mononuclear cells from patients with HCC, liver diseases devoid of cancer, non-hepatic tumors, and healthy controls, respectively. IGF-II cDNAs were synthesized through random primers and reverse-transcriptase, amplified by polymerase chain reaction (PCR), and confirmed by DNA sequencing analysis. Serum free IGF-II levels in patients with different liver diseases were analyzed by an enzyme-linked immunosorbent assay. RESULTS: The amplified fragments of IGF-II mRNA by RT-PCR were identical to originally designed ones with a size of 170 bp and confirmed by sequencing analysis. The dilution experiments revealed that the lowest sensitivity of our system was 2 ng/L of total RNA. The positive frequencies of IGF-II mRNA were 100% in HCC tissues, 53.3% in para-cancerous tissues, and 0% in non-cancerous tissues, respectively. The serum free IGF-II levels were significantly higher in HCC than those in chronic hepatitis or liver cirrhosis. The positive frequency of circulating IGF-II mRNA was 34.2% in HCC, no amplified fragment was found in other liver diseases, extrahepatic tumors, and normal controls, respectively. The circulating IGF-II mRNA correlated with the stage of HCC, and its positive rate was 100% in HCC with extrahepatic metastasis and 35.5% in HCC with AFP-negative. No significant correlation was found between tumor sizes and circulating IGF-II mRNA fragment. CONCLUSION: The abnormal expressions of free IGF-II and IGF-II mRNA are useful tumor markers for HCC diagnosis, differentiation of extrahepatic metastasis and monitoring postoperative recurrence. (C) 2005 The WJG Press and Elsevier Inc. All rights reserved.
引用
收藏
页码:4655 / 4660
页数:6
相关论文
共 42 条
[1]
Allelic imbalance of insulin-like growth factor II gene expression in cancerous and precancerous lesions of the liver [J].
Aihara, T ;
Noguchi, S ;
Miyoshi, Y ;
Nakano, H ;
Sasaki, Y ;
Nakamura, Y ;
Monden, M ;
Imaoka, S .
HEPATOLOGY, 1998, 28 (01) :86-89
[2]
[Anonymous], 2000, ZHONGHUA GAN ZANG BI
[3]
[Anonymous], ZHONGHUA GANZANGBING
[4]
Insulin-like growth factor II (IGF-II) secreted from HepG2 human hepatocellular carcinoma cells shows angiogenic activity [J].
Bae, MH ;
Lee, MJ ;
Bae, SK ;
Lee, OH ;
Lee, YM ;
Park, BC ;
Kim, KW .
CANCER LETTERS, 1998, 128 (01) :41-46
[5]
MEMBERS OF THE HUMAN GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE-RELATED GENE FAMILY MAP TO DISPERSED CHROMOSOMAL LOCATIONS [J].
BENHAM, FJ ;
POVEY, S .
GENOMICS, 1989, 5 (02) :209-214
[6]
Angiogenesis in health and disease [J].
Carmeliet, P .
NATURE MEDICINE, 2003, 9 (06) :653-660
[7]
DIFFERENT IN-SITU EXPRESSION OF INSULIN-LIKE GROWTH-FACTOR TYPE-II IN HEPATOCELLULAR-CARCINOMA - AN IN-SITU HYBRIDIZATION AND IMMUNOHISTOCHEMICAL STUDY [J].
FIORENTINO, M ;
GRIGIONI, WF ;
BACCARINI, P ;
DERRICO, A ;
DEMITRI, MS ;
PISI, E ;
MANCINI, AM .
DIAGNOSTIC MOLECULAR PATHOLOGY, 1994, 3 (01) :59-65
[8]
Hematogenous spreading of hepatocellular carcinoma cells: Possible participation in recurrence in the liver [J].
Funaki, NO ;
Tanaka, J ;
Seto, SI ;
Kasamatsu, T ;
Kaido, T ;
Imamura, M .
HEPATOLOGY, 1997, 25 (03) :564-568
[9]
Huynh H, 2002, CELL GROWTH DIFFER, V13, P115
[10]
α-Fetoprotein mRNA in the circulation as a predictor of postsurgical recurrence of hepatocellular carcinoma:: A prospective study [J].
Ijichi, M ;
Takayama, T ;
Matsumura, M ;
Shiratori, Y ;
Omata, M ;
Makuuchi, M .
HEPATOLOGY, 2002, 35 (04) :853-860